DermaClip US Medical Advisors Submit Paper for Publication in Military Medicine Journal

DermaClip Manuscript, Submission to Military Medicine Journal

New York, NY – 1/15/2017. Dr. Jeffrey Freed, MD, MPH, FACS, FACG, and Dr. John Ko, MD, PhD, FACS, submitted a manuscript to the Military Medicine Journal on the use of the DermaClip® non-invasive, needle-less skin closure device and its applicability in the military setting. The paper reviews a trial of the efficacy of the device where DermaClip® was tested in a 120 patient trial, composed of 60 experimental cases and 60 control cases.  DermaClip® is a non-invasive, painless, easy-to-apply wound closure device that does not require painful anesthesia injections or create additional damage to the wounded area. The paper points out that in the military environment, where there are some 2 million injuries each year, the DermaClip® device could constructively assist in mitigating this leading health and readiness threat to the armed forces. 

Drs. Freed and Ko are both members of the DermaClip® Medical Advisory Board with extensive use of the device.  The submission was a follow-up to the oral presentation on DermaClip® that Dr. Freed, Chairman of the Medical Advisory Board, gave in person at the 2016 Military Health System Research Symposium (MHSRS) in 2016 in Orlando.  A full copy of the submission can be found here.  This version has not been peered reviewed.

About DermaClip®

The DermaClip® skin closure device is a unique, newly-developed non-invasive skin closure device made of hypoallergenic adhesive coupled with a polypropylene bridge that allows for the quick and easy approximation of skin edges at the time of final closure of a wound. It removes the necessity for local anesthesia, alleviates skin puncture by sutures and staples, and eliminates the possibility of skin reaction to glues, eliminating potential sources of pain and complications for the patient. The patented single-use, needle-less device is designed to evert skin edges, avoiding the possibility of unsightly wound inversion. The device accomplishes this with remarkable speed allowing for decreased preparation, time-to-closure and absence of staple or suture cross-hatching. This results in decreased overall costs while being designed to improve the cosmesis of wound healing.

We, at DermaClip®, believe that this high quality skin closure system should be available to everyone, allowing all involved in wound closure -- the patient, the medical professional and the institutions providing the service -- to benefit from the advantages of this product.

The US operations of DermaClip® are owned and operated by DermaClip® US, L.L.C., a Texas based company.